Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

FDA updates labeling for TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 26
  • 0 comments

Labeling changes approved for MACLEODS PHARMS LTD. Active ingredient: ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE. Decision date: 12/15/2025

Comment Full text

FDA updates labeling for TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 20
  • 0 comments

Labeling changes approved for AUROBINDO PHARMA. Active ingredient: ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE. Decision date: 12/15/2025

Comment Full text

FDA approves BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE from ASCENT PHARMS INC

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 15
  • 0 comments

Final approval of ANDA #ANDA #219727 for BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE. Decision date: 12/15/2025

Comment Full text

FDA approves CARIPRAZINE HYDROCHLORIDE from AUROBINDO PHARMA LTD

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 23
  • 0 comments

Final approval of ANDA #ANDA #213982 for CARIPRAZINE HYDROCHLORIDE. Decision date: 12/16/2025

Comment Full text

FDA updates labeling for CLARISCAN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 17
  • 0 comments

Labeling changes approved for GE HEALTHCARE. Active ingredient: GADOTERATE MEGLUMINE. Decision date: 12/15/2025

Comment Full text

FDA updates labeling for TIZANIDINE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 27
  • 0 comments

Labeling changes approved for APOTEX INC. Active ingredient: TIZANIDINE HYDROCHLORIDE. Decision date: 12/16/2025

Comment Full text

FDA approves BECLOMETHASONE DIPROPIONATE from AMNEAL IRELAND LTD

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 22
  • 0 comments

Final approval of ANDA #ANDA #213811 for BECLOMETHASONE DIPROPIONATE. Decision date: 12/16/2025

Comment Full text

FDA updates labeling for ACETAMINOPHEN AND IBUPROFEN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 23
  • 0 comments

Labeling changes approved for GRANULES. Active ingredient: ACETAMINOPHEN; IBUPROFEN. Decision date: 12/17/2025

Comment Full text

FDA updates labeling for TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 21
  • 0 comments

Labeling changes approved for ALKEM LABS LTD. Active ingredient: ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE. Decision date: 12/15/2025

Comment Full text

FDA regulatory update for ENHERTU

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 23
  • 0 comments

Administrative update #SUPPL-38 for DAIICHI SANKYO. Status: Approval. Decision date: 12/15/2025

Comment Full text
  • Previous
  • 28
  • 29
  • 30
  • 31
  • 32
  • Next

Search

News categories

  • Technical Exchange News(11248)
  • Event(2611)
  • SEC News(198387)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(131514)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin